The global Hematopoietic Stem Cell Transplantation (HSCT) Market Growth Accelerated by Technological Advancements

 Hematopoietic stem cell transplantation (HSCT) involves transplantation of healthy stem cells from a matched/unmatched donor to replace the damaged or destroyed hematopoietic stem cells in a patient suffering from blood cancers like leukemia or disorders. HSCT is useful in treating over 80 types of life-threatening diseases. The procedure involves using high-dose chemotherapy and/or radiation therapy to destroy unhealthy blood and bone marrow stem cells, followed by replacement with healthy stem cells.

The global Hematopoietic Stem Cell Transplantation (HSCT) Market is estimated to be valued at US$ 2.88 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Technological advancements in HSCT procedures are fueling market growth. For instance, advanced technologies facilitate the identification and isolation of hematopoietic stem cells from peripheral blood, bone marrow, umbilical cord blood, and other sources. Further, the development of humanized mouse models to study human hematopoietic stem cell engraftment and expansion have improved transplant success rates. Novel systems facilitate the tracking and enumeration of transplanted human hematopoietic cells and their progeny in living animals. Such technological improvements are enhancing the safety and efficacy of HSCT procedures, thereby accelerating market revenues.

Segment Analysis
The global hematopoietic stem cell transplantation (HSCT) market is dominated by the allogeneic stem cell transplantation sub-segment due to the wide acceptance and success rate of transplantation from a healthy donor. Allogeneic HSCT accounts for over 70% of the total HSCT procedures performed globally each year.

Key Takeaways
The global hematopoietic stem cell transplantation (HSCT) market is expected to witness high growth over the forecast period of 2023-2030. The global Hematopoietic Stem Cell Transplantation (HSCT) Market is estimated to be valued at US$ 2.88 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.

Regional analysis:
North America region accounted for the largest share in the HSCT market in 2023 due to strong presence of leading market players, higher adoption rate of advanced technologies, growing research activities for stem cell therapies, and awareness pertaining to life-threatening diseases. However, Asia Pacific is expected to register the highest CAGR during the forecast period due to rising prevalence of blood disorders and cancers requiring HSCT procedures, developing healthcare infrastructure, and initiatives by governments & private organizations to increase funding for research activities.

Key players:
Key players operating in the hematopoietic stem cell transplantation (HSCT) market are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Inc., Talaris Therapeutics, Inc., Marker Therapeutics Inc., Stempeutics Research Pvt Ltd., CBR Systems Inc., Priothera Ltd., Eurobio Scientific Group, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Sanofi, FUJIFILM Holdings Corporation.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more